2013
DOI: 10.1371/journal.pone.0058874
|View full text |Cite
|
Sign up to set email alerts
|

A Readily Applicable Strategy to Convert Peptides to Peptoid-based Therapeutics

Abstract: Incorporation of unnatural amino acids and peptidomimetic residues into therapeutic peptides is highly efficacious and commonly employed, but generally requires laborious trial-and-error approaches. Previously, we demonstrated that C20 peptide has the potential to be a potential antiviral agent. Herein we report our attempt to improve the biological properties of this peptide by introducing peptidomimetics. Through combined alanine, proline, and sarcosine scans coupled with a competitive fluorescence polarizat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 42 publications
0
19
0
Order By: Relevance
“…These unique features of peptoids may aid in revealing salient features of protein–protein interactions. 32 For example, the X-ray crystallographic structure of a peptomeric analogue of SFTI-1 containing N Lys in the P1 subsite revealed an interesting mechanism of proteolytic resistance. 39 The peptomer also provided insights into the mechanism of action of the serine protease family.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These unique features of peptoids may aid in revealing salient features of protein–protein interactions. 32 For example, the X-ray crystallographic structure of a peptomeric analogue of SFTI-1 containing N Lys in the P1 subsite revealed an interesting mechanism of proteolytic resistance. 39 The peptomer also provided insights into the mechanism of action of the serine protease family.…”
Section: Discussionmentioning
confidence: 99%
“…31 Systematic substitution of natural amino acids using peptoid residues can be considered as “peptoid scanning” that in principle is similar to the Ala scan commonly employed and provides valuable structural insight into protein–protein interactions. 32 …”
mentioning
confidence: 99%
“…A3G bound nine Vif-derived peptides from three distinct regions in Vif: residues 8-45 from the NTD, residues 154-192 from the CTD containing the conserved motif 161 PPLP 164 and a central region between residues 83-99 [230,231]. The A3G-derived peptides A3G [143][144][145][146][147][148][149][150][151][152][153][154][155][156][157] , A3G and A3G [263][264][265][266][267][268][269][270][271][272][273][274][275][276][277] bound fulllength Vif and Vif-CTD. The peptide array experiment revealed that peptides A3G 31-52 , A3G [166][167][168][169][170][171][172][173][174][175][176][177][178][179][180] , A3G 211-...…”
Section: (C) the Tat-p53 Interactionmentioning
confidence: 99%
“…The peptide, Fuzeon ® (Enfuvirtide) was approved for clinical use against HIV [84][85][86]268,269]. Current research in anti-HIV drug design is focused on stabilizing lead peptides using different strategies such as cyclization, peptoids and more [268][269][270][271][272][273].…”
Section: Conclusion and Future Perspectivementioning
confidence: 99%
“…More recently, the modulation of peptoid helicity using the sergeant-and-solider effect was demonstrated [ 34 ]. The established solid phase peptoid synthesis method [ 35 ] and efficient post-synthetic modifications [ 36 , 37 , 38 , 39 , 40 , 41 ] afforded peptoids with greater structural diversity, thereby leading to their application in various functional entities including bioactive agents [ 42 , 43 , 44 , 45 , 46 , 47 ], biomimetic materials [ 48 , 49 , 50 , 51 ], sensors [ 52 , 53 ], and metal-chelating ligands [ 48 , 54 , 55 , 56 , 57 , 58 , 59 ].…”
Section: Introductionmentioning
confidence: 99%